Carl L. Gordon - Feb 9, 2024 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role: Director, 10%+ Owner
Signature: /s/ Neil Lerner, attorney-in-fact
Stock symbol: CMPX
Transactions as of: Feb 9, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/14/2024, 12:02 PM
Previous filing: Jan 31, 2024
Next filing: Feb 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMPX	Stock Option (Right to Buy)	Award	$0	+40K		$0.00	40K	Feb 9, 2024	Common Stock	40K	$1.57	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest over 48 substantially equal monthly installments starting March 9, 2024.
F2	The Reporting Person is a member of OrbiMed Advisors LLC ("OrbiMed Advisors"). Pursuant to an agreement with OrbiMed Advisors, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors and OrbiMed Capital GP V LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments V-KA, LP.

Content

The options vest over 48 substantially equal monthly installments starting March 9, 2024.

The Reporting Person is a member of OrbiMed Advisors LLC ("OrbiMed Advisors"). Pursuant to an agreement with OrbiMed Advisors, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors and OrbiMed Capital GP V LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments V-KA, LP.